Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

LAMEA Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Country and Growth Forecast, 2023 - 2030

Published Date : 31-Jul-2023

Pages: 121

Formats: PDF

The Latin America, Middle East and Africa Allergy Immunotherapy Market would witness market growth of 12.9% CAGR during the forecast period (2023-2030).

Due to the rising incidence of allergies and the desire for efficient treatment alternatives, the market is predicted to rise steadily throughout this time. The development of alternative immunotherapeutic medications, such as oral drops, sublingual tablets, and other types of allergy immunotherapy, may further aid in the market's expansion. The market is anticipated to grow significantly throughout this time due to the introduction of new goods and technology. Market expansion is anticipated due to the development of cutting-edge immunotherapy therapies such as immunoglobulin E (IgE) inhibitors, biologics, and gene therapies.

The market will have significant long-term growth possibilities in the future due to the rising need for individualized and successful allergy treatments from patients, doctors, and healthcare systems. Additionally, the growing need for personalized healthcare and precision medicine will probably spur the creation of novel immunotherapy treatments customized to the needs of each patient. The main factors driving the market are the rising prevalence of different types of allergies and the introduction of innovative sublingual immunotherapies in emerging nations. The increasing prevalence of various types of allergies is one of the key factors driving the market.

Large portions of the Middle East are desert. While the summer months might be hot and humid, the winter months can see considerable drops in temperature. These climatic fluctuations have the potential to aggravate chronic respiratory disorders in sensitive patients, notably asthmatics. The Asthma Program of the Department of Health seeks to reduce visits to emergency rooms, hospitalizations, absences from work and school, and, most significantly, asthma-related fatalities. The rising asthma cases and the continues working towards its treatment will surge the usage of medicine like bronchodilators and hence boost the market growth.

The Brazil market dominated the LAMEA Allergy Immunotherapy Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $57.8 million by 2030. The Argentina market is anticipated to grow at a CAGR of 13.5% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 12.6% during (2023 - 2030).

Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on Treatment Type, the market is segmented into Subcutaneous Immunotherapy (SCIT), and Sublingual Immunotherapy (SLIT) (Tablets, and Drops). Based on Allergy Type, the market is segmented into Allergic Rhinitis, Allergic Asthma, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Allergy Immunotherapy Market is Projected to reach USD 2.9 Billion by 2030, at a CAGR of 8.4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc. (Mylan N.V.), Merck KGaA , NIOX Group plc , DMS Imaging SA, Adamis Pharmaceuticals Corporation, Stallergenes Greer International AG (B-Flexion), Allergy Therapeutics plc , DBV Technologies S.A., HAL Allergy B.V. (Droege International Group AG.), LETI Pharma, S.L.U.

Scope of the Study

Market Segments Covered in the Report:

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Treatment Type

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
    • Tablets
    • Drops

By Allergy Type

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Viatris, Inc. (Mylan N.V.)
  • Merck KGaA
  • NIOX Group plc
  • DMS Imaging SA
  • Adamis Pharmaceuticals Corporation
  • Stallergenes Greer International AG (B-Flexion)
  • Allergy Therapeutics plc
  • DBV Technologies S.A.
  • HAL Allergy B.V. (Droege International Group AG.)
  • LETI Pharma, S.L.U.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Allergy Immunotherapy Market, by Distribution Channel
1.4.2 LAMEA Allergy Immunotherapy Market, by Treatment Type
1.4.3 LAMEA Allergy Immunotherapy Market, by Allergy Type
1.4.4 LAMEA Allergy Immunotherapy Market, by Country
1.5 Methodology for the research

Chapter 2. Market At a Glance
2.1 Key Highlight

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis

Chapter 4. LAMEA Allergy Immunotherapy Market by Distribution Channel
4.1 LAMEA Retail Pharmacy Market by Country
4.2 LAMEA Hospital Pharmacy Market by Country
4.3 LAMEA Online Pharmacy Market by Country

Chapter 5. LAMEA Allergy Immunotherapy Market by Treatment Type
5.1 LAMEA Subcutaneous Immunotherapy (SCIT) Market by Country
5.2 LAMEA Sublingual Immunotherapy (SLIT) Market by Country
5.3 LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
5.3.1 LAMEA Tablets Market by Country
5.3.2 LAMEA Drops Market by Country

Chapter 6. LAMEA Allergy Immunotherapy Market by Allergy Type
6.1 LAMEA Allergic Rhinitis Market by Country
6.2 LAMEA Allergic Asthma Market by Country
6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Allergy Immunotherapy Market by Country
7.1 Brazil Allergy Immunotherapy Market
7.1.1 Brazil Allergy Immunotherapy Market by Distribution Channel
7.1.2 Brazil Allergy Immunotherapy Market by Treatment Type
7.1.2.1 Brazil Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.1.3 Brazil Allergy Immunotherapy Market by Allergy Type
7.2 Argentina Allergy Immunotherapy Market
7.2.1 Argentina Allergy Immunotherapy Market by Distribution Channel
7.2.2 Argentina Allergy Immunotherapy Market by Treatment Type
7.2.2.1 Argentina Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.2.3 Argentina Allergy Immunotherapy Market by Allergy Type
7.3 UAE Allergy Immunotherapy Market
7.3.1 UAE Allergy Immunotherapy Market by Distribution Channel
7.3.2 UAE Allergy Immunotherapy Market by Treatment Type
7.3.2.1 UAE Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.3.3 UAE Allergy Immunotherapy Market by Allergy Type
7.4 Saudi Arabia Allergy Immunotherapy Market
7.4.1 Saudi Arabia Allergy Immunotherapy Market by Distribution Channel
7.4.2 Saudi Arabia Allergy Immunotherapy Market by Treatment Type
7.4.2.1 Saudi Arabia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.4.3 Saudi Arabia Allergy Immunotherapy Market by Allergy Type
7.5 South Africa Allergy Immunotherapy Market
7.5.1 South Africa Allergy Immunotherapy Market by Distribution Channel
7.5.2 South Africa Allergy Immunotherapy Market by Treatment Type
7.5.2.1 South Africa Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.5.3 South Africa Allergy Immunotherapy Market by Allergy Type
7.6 Nigeria Allergy Immunotherapy Market
7.6.1 Nigeria Allergy Immunotherapy Market by Distribution Channel
7.6.2 Nigeria Allergy Immunotherapy Market by Treatment Type
7.6.2.1 Nigeria Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.6.3 Nigeria Allergy Immunotherapy Market by Allergy Type
7.7 Rest of LAMEA Allergy Immunotherapy Market
7.7.1 Rest of LAMEA Allergy Immunotherapy Market by Distribution Channel
7.7.2 Rest of LAMEA Allergy Immunotherapy Market by Treatment Type
7.7.2.1 Rest of LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.7.3 Rest of LAMEA Allergy Immunotherapy Market by Allergy Type

Chapter 8. Company Profiles
8.1 Viatris, Inc. (Mylan N.V.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Merck KGaA
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 NIOX Group plc
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 DMS Imaging SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 SWOT Analysis
8.5 Adamis Pharmaceuticals Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 SWOT Analysis
8.6 Stallergenes Greer International AG (B-Flexion)
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Acquisition and Mergers:
8.6.3 SWOT Analysis
8.7 Allergy Therapeutics plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 DBV Technologies S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.8.4 SWOT Analysis
8.9 HAL Allergy B.V. (Droege International Group AG.)
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. LETI Pharma, S.L.U.
8.10.1 Company Overview
TABLE 1 LAMEA Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 LAMEA Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 12 LAMEA Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 13 LAMEA Subcutaneous Immunotherapy (SCIT) Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Subcutaneous Immunotherapy (SCIT) Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Sublingual Immunotherapy (SLIT) Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Sublingual Immunotherapy (SLIT) Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 18 LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 19 LAMEA Tablets Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Tablets Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Drops Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Drops Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 24 LAMEA Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 25 LAMEA Allergic Rhinitis Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Allergic Rhinitis Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Allergic Asthma Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Allergic Asthma Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Allergy Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Allergy Immunotherapy Market by Country, 2023 - 2030, USD Million
TABLE 33 Brazil Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 34 Brazil Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 35 Brazil Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 Brazil Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Brazil Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 38 Brazil Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 39 Brazil Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 40 Brazil Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 41 Brazil Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 42 Brazil Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 43 Argentina Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 44 Argentina Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 45 Argentina Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Argentina Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Argentina Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 48 Argentina Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 49 Argentina Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 50 Argentina Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 51 Argentina Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 52 Argentina Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 53 UAE Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 54 UAE Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 55 UAE Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 UAE Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 UAE Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 58 UAE Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 59 UAE Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 60 UAE Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 61 UAE Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 62 UAE Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 63 Saudi Arabia Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 65 Saudi Arabia Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Saudi Arabia Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Saudi Arabia Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 68 Saudi Arabia Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 69 Saudi Arabia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 70 Saudi Arabia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 71 Saudi Arabia Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 72 Saudi Arabia Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 73 South Africa Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 74 South Africa Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 75 South Africa Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 76 South Africa Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 77 South Africa Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 78 South Africa Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 79 South Africa Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 80 South Africa Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 81 South Africa Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 82 South Africa Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 83 Nigeria Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 84 Nigeria Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 85 Nigeria Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Nigeria Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 87 Nigeria Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 88 Nigeria Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 89 Nigeria Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 90 Nigeria Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 91 Nigeria Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 92 Nigeria Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 93 Rest of LAMEA Allergy Immunotherapy Market, 2019 - 2022, USD Million
TABLE 94 Rest of LAMEA Allergy Immunotherapy Market, 2023 - 2030, USD Million
TABLE 95 Rest of LAMEA Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 96 Rest of LAMEA Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 97 Rest of LAMEA Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
TABLE 98 Rest of LAMEA Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
TABLE 99 Rest of LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
TABLE 100 Rest of LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
TABLE 101 Rest of LAMEA Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
TABLE 102 Rest of LAMEA Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
TABLE 103 key information – Viatris, Inc.
TABLE 104 key Information – Merck KGaA
TABLE 105 Key Information – NIOX Group plc
TABLE 106 Key Information – DMS Imaging SA
TABLE 107 Key Information – Adamis Pharmaceuticals Corporation
TABLE 108 Key Information – Stallergenes Greer International AG
TABLE 109 Key Information – Allergy Therapeutics plc
TABLE 110 Key Information – DBV TECHNOLOGIES S.A.
TABLE 111 Key Information – HAL Allergy B.V.
TABLE 112 Key Information – LETI Pharma, S.L.U.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Allergy Immunotherapy Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Allergy Immunotherapy Market
FIG 4 Porter’s Five Forces Analysis - Allergy Immunotherapy Market
FIG 5 LAMEA Allergy Immunotherapy Market share by Distribution Channel, 2022
FIG 6 LAMEA Allergy Immunotherapy Market share by Distribution Channel, 2030
FIG 7 LAMEA Allergy Immunotherapy Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 LAMEA Allergy Immunotherapy Market share by Treatment Type, 2022
FIG 9 LAMEA Allergy Immunotherapy Market share by Treatment Type, 2030
FIG 10 LAMEA Allergy Immunotherapy Market by Treatment Type, 2019 - 2030, USD Million
FIG 11 LAMEA Allergy Immunotherapy Market share by Allergy Type, 2022
FIG 12 LAMEA Allergy Immunotherapy Market share by Allergy Type, 2030
FIG 13 LAMEA Allergy Immunotherapy Market by Allergy Type, 2019 - 2030, USD Million
FIG 14 LAMEA Allergy Immunotherapy Market share by Country, 2022
FIG 15 LAMEA Allergy Immunotherapy Market share by Country, 2030
FIG 16 LAMEA Allergy Immunotherapy Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Viatris, Inc.
FIG 18 Swot Analysis: Merck KGaA
FIG 19 SWOT Analysis: NIOX Group plc
FIG 20 SWOT Analysis: DMS Imaging SA
FIG 21 SWOT Analysis: Adamis Pharmaceuticals Corporation
FIG 22 Recent strategies and developments: Stallergenes Greer International AG
FIG 23 SWOT Analysis: Stallergenes Greer International AG
FIG 24 SWOT Analysis: Allergy Therapeutics plc
FIG 25 SWOT Analysis: DBV Technologies S.A.
FIG 26 SWOT Analysis: HAL Allergy B.V.

Purchase Full Report of
LAMEA Allergy Immunotherapy Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL